Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.

Cancer Cell
Rui SuJianjun Chen

Abstract

Fat mass and obesity-associated protein (FTO), an RNA N6-methyladenosine (m6A) demethylase, plays oncogenic roles in various cancers, presenting an opportunity for the development of effective targeted therapeutics. Here, we report two potent small-molecule FTO inhibitors that exhibit strong anti-tumor effects in multiple types of cancers. We show that genetic depletion and pharmacological inhibition of FTO dramatically attenuate leukemia stem/initiating cell self-renewal and reprogram immune response by suppressing expression of immune checkpoint genes, especially LILRB4. FTO inhibition sensitizes leukemia cells to T cell cytotoxicity and overcomes hypomethylating agent-induced immune evasion. Our study demonstrates that FTO plays critical roles in cancer stem cell self-renewal and immune evasion and highlights the broad potential of targeting FTO for cancer therapy.

References

Jan 1, 1990·Cancer Chemotherapy and Pharmacology·G SchwartsmannM B van Hennik
Jan 1, 1986·Cancer Chemotherapy and Pharmacology·T P MillerS E Jones
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M de ForniA Gouyette
Oct 10, 1998·Journal of Virology·T DullL Naldini
Jun 6, 2000·Advanced Drug Delivery Reviews·F Hirayama, K Uekama
Mar 22, 2003·RNA·Sheila A StewartCarl D Novina
Mar 19, 2004·Journal of Medicinal Chemistry·Richard A FriesnerPeter S Shenkin
Jan 6, 2005·Journal of the American Chemical Society·Jeffrey R HuthPhilip J Hajduk
Oct 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Aravind SubramanianJill P Mesirov
Jul 25, 2006·Nature·Andrei V KrivtsovScott A Armstrong
Nov 6, 2007·Trends in Molecular Medicine·Daniela S Krause, Richard A Van Etten
Apr 23, 2008·Current Protocols in Human Genetics·Patrick Salmon, Didier Trono
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Raanan BergerArnon Nagler
Dec 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Brett LomenickJing Huang
Oct 18, 2011·Nature Chemical Biology·Guifang JiaChuan He
Apr 21, 2012·Briefings in Bioinformatics·Helga ThorvaldsdóttirJill P Mesirov
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Oct 11, 2012·Journal of the American Chemical Society·Baoen ChenCai-Guang Yang
Oct 30, 2012·Bioinformatics·Alexander DobinThomas R Gingeras
Dec 12, 2012·Trends in Genetics : TIG·Guifang JiaChuan He
May 3, 2013·The New England Journal of Medicine·UNKNOWN Cancer Genome Atlas Research NetworkGreg Eley
Dec 25, 2013·The Journal of Experimental Medicine·Ewa OhlssonBo Torben Porse
May 20, 2014·ACS Chemical Neuroscience·Guanqun ZhengMark J Olsen
Dec 1, 2004·Drug Discovery Today. Technologies·Christopher A Lipinski
Jul 31, 2014·Nature Methods·Neville E SanjanaFeng Zhang
Aug 8, 2014·Nature Protocols·Rozbeh JafariDaniel Martinez Molina
Dec 3, 2014·Nucleic Acids Research·Yue HuangCai-Guang Yang
Dec 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory L Beatty, Whitney L Gladney
May 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amita PatnaikAnthony W Tolcher
Oct 13, 2015·Journal of the American Chemical Society·Tianlu WangXiang Zhou

❮ Previous
Next ❯

Citations

Jul 1, 2020·Nature Reviews. Drug Discovery·Megan Cully
Sep 30, 2020·Proceedings of the National Academy of Sciences of the United States of America·Joel D W TohChristopher J Chang
Oct 20, 2020·Epigenetics : Official Journal of the DNA Methylation Society·Zhonghua MaJiafu Ji
Nov 8, 2020·European Journal of Haematology·Jonathan CanaaniArnon Nagler
Nov 27, 2020·Frontiers in Cell and Developmental Biology·Shengchao XuZhixiong Liu
Jan 7, 2021·Cell Reports·Peiwen ChenRonald A DePinho
Nov 6, 2020·Leukemia·Irina A Elcheva, Vladimir S Spiegelman
Jan 13, 2021·International Journal of Molecular Sciences·Ligia I TorsinGeorge A Calin
Dec 29, 2020·Medicinal Research Reviews·Fanwang MengCheng Luo
Dec 30, 2020·Cancer Cell International·Shanshan XieXiaoyi Yan
Feb 22, 2021·Signal Transduction and Targeted Therapy·Xiulin JiangYongbin Chen
Mar 21, 2021·Nature Communications·Sébastien RelierAlexandre David
Mar 20, 2021·Molecular Therapy. Nucleic Acids·Hui LiDa Pang
Mar 30, 2021·Regenerative Therapy·Hiroyuki Tsuchiya, Goshi Shiota
Mar 30, 2021·Frontiers in Immunology·Maorun ZhangZhenqiang Sun
Apr 13, 2021·Frontiers in Cell and Developmental Biology·Xin Du, Hai Hu
Apr 12, 2021·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yunru GuPei Ma
May 1, 2021·Journal of Experimental & Clinical Cancer Research : CR·Fenghua TanCan Guo
May 1, 2021·Antibody Therapeutics·Mi DengCheng Cheng Zhang
May 7, 2021·Cancer Communications·Shenghua DongHuilin Huang
May 19, 2021·Biomarker Research·Xue Zheng, Yuping Gong
May 18, 2021·Neoplasia : an International Journal for Oncology Research·Runping FangHui Shi
Jun 8, 2021·Frontiers in Oncology·Yujie ZhangBin Han
Jun 22, 2021·Frontiers in Pharmacology·Wen-Min ZhouJian-Ye Zhang
Jul 9, 2021·Frontiers in Cell and Developmental Biology·Martina Mang Leng Lei, Terence Kin Wah Lee
Jul 10, 2021·Future Medicinal Chemistry·Shuting GaoJunbiao Chang
Jul 29, 2021·Journal of Hematology & Oncology·Wei HuangYue-Qin Chen
Jul 1, 2021·Oncology Letters·Mingying Zhang, Shubin Wang
Aug 13, 2021·Aging·Ying QingJianjun Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.